This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, Y. Articles by Davidson, N. E. Search for Related Content PubMed PubMed Citation Articles by Huang, Y. Articles by Davidson, N. E.

---

Cancer Genes and Genomics

Regulation of Polyamine Analogue Cytotoxicity by c-Jun in Human MDA-MB-435 Cancer Cells¹

¹ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD and² SLIL Biomedical Corp., Madison, WI

Requests for reprints: Nancy E. Davidson, Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, Room 409, Baltimore, MD 21231. Phone: (410) 955-8489; Fax: (410) 614-4073. E-mail: davidna{at}jhmi.edu

Several polyamine analogues have efficacy against a variety of epithelial tumor models including breast cancer. Recently, a novel class of polyamine analogues designated as oligoamines has been developed. Here, we demonstrate that several representative oligoamine compounds inhibit in vitro growth of human breast cancer MDA-MB-435 cells. The activator protein-1 (AP-1) transcriptional factor family members, c-Jun and c-Fos, are up-regulated by oligoamines in MDA-MB-435 cells, suggesting a possible AP-1-dependent induction of apoptosis. However, the use of a novel c-Jun NH₂-terminal kinase (JNK) inhibitor, SP600125, suggests that inhibition of c-Jun activity sensitized tumor cells to oligoamine-induced cell death. To directly test this hypothesis, cells were stably transfected with the dominant-negative mutant c-Jun (TAM67), which lacks the NH₂-terminal transactivation domain. Cells overexpressing TAM67 exhibit normal growth kinetics but demonstrate a significantly increased sensitivity to oligoamine cytotoxicity and attenuated colony formation after oligoamine treatment. Furthermore, oligoamine treatment leads to more profound caspase-3 activation and poly(ADP-ribose) polymerase cleavage in TAM67 transfectants, suggesting that c-Jun acts as an antiapoptosis factor in MDA-MB-435 cells in response to oligoamine treatment. These findings indicate that oligoamine-inducible AP-1 plays a prosurvival role in oligoamine-treated MDA-MB-435 cells and that JNK/AP-1 might be a potential target for enhancing the therapeutic efficacy of polyamine analogues in human breast cancer.

This article has been cited by other articles:

				Y. Huang, J. C. Keen, A. Pledgie, L. J. Marton, T. Zhu, S. Sukumar, B. H. Park, B. Blair, K. Brenner, R. A. Casero Jr, et al. Polyamine Analogues Down-regulate Estrogen Receptor {alpha} Expression in Human Breast Cancer Cells J. Biol. Chem., July 14, 2006; 281(28): 19055 - 19063. [Abstract] [Full Text] [PDF]

				S.-L. Liang, H. Liu, and A. Zhou Lovastatin-Induced Apoptosis in Macrophages through the Rac1/Cdc42/JNK Pathway J. Immunol., July 1, 2006; 177(1): 651 - 656. [Abstract] [Full Text] [PDF]

				R. L. e Silva, Y. Saishin, Y. Saishin, H. Akiyama, S. Kachi, S. Aslam, B. Rogers, T. Deering, Y. Y. Gong, S. F. Hackett, et al. Suppression and Regression of Choroidal Neovascularization by Polyamine Analogues Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3323 - 3330. [Abstract] [Full Text] [PDF]